The 20 references in paper I. Shirinsky V., V. Shirinsky S., C. Dinarello A., И. Ширинский В., В. Ширинский С., C. Dinarello A. (2014) “ВЛИЯНИЕ МЕВАСТАТИНА И БИОЛОГИЧЕСКИХ ПРЕПАРАТОВ НА АКТИВАЦИЮ ВЭБ-СПЕЦИФИЧНЫХ CD4+ ЛИМФОЦИТОВ У БОЛЬНЫХ РЕВМАТОИДНЫМ АРТРИТОМ IN VITRO // IN VITRO EFFECTS OF MEVASTATIN AND BIOLOGICAL PREPARATIONS UPON ACTIVATION OF EBV-SPECIFIC CD4+T LYMPHOCYTES FROM THE PATIENTS WITH RHEUMATOID ARTHRITIS” / spz:neicon:mimmun:y:2011:i:3:p:285-290

1
Ширинский И.В., Желтова О.И., Соловьева Н.Ю., Ширинский В.С. Влияние статинов на пролиферацию лимфоцитов при ревматоидном артрите // Аллергология и иммунология. –
(check this in PDF content)
2
07. – No 4. – С. 380-383. 2. Ширинский И.В., Желтова О.И., Соловьева Н.Ю., Ширинский В.С., Козлов В.А. Эффективность и безопасность симвастатина при ревматоидном артрите – открытое контролируемое исследование // Медицинская иммунология. – 2007. – No 4-5. – С. 477-482.
(check this in PDF content)
3
Asten P., Barrett J., Symmons D. Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases // J. Rheumatol. – 1999. – Vol. 26. – P. 1705-1714.
(check this in PDF content)
4
Aversa G., Punnonen J., de Vries J.E. The 26kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation // J. Exp. Med. – 1993. – Vol. 177. – P. 1575-1585.
(check this in PDF content)
5
Baecklund E., Askling J., Rosenquist R., Ekbom A., Klareskog L. Rheumatoid arthritis and malignant lymphomas // Curr. Opin. Rheumatol. – 2004. – Vol. 16. – P. 254-261.
(check this in PDF content)
6
Balandraud N., Roudier J., Roudier C. Epstein–Barr virus and rheumatoid arthritis // Autoimmun Rev. – 2004. – Vol. 3. – P. 362-367.
(check this in PDF content)
7
Feng W.H., Cohen J.I., Fischer S., Li L., Sneller M., Goldbach-Mansky R., Raab-Traub N., Delecluse H.J., Kenney S.C. Reactivation of latent Epstein–Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas // J. Natl. Cancer Inst. – 2004. – Vol. 96. – P. 16911702.
(check this in PDF content)
8
Hober D., De Groote D., Vanpouille N., Dehart I., Shen L., Wattre P., Maniez-Montreuil M. Tumor necrosis factor receptor expression in HIV1-infected CD4+ T cells // Microbiol. Immunol. – 1994. – Vol. 38. – P. 1005-1008.
(check this in PDF content)
9
Jones M., Symmons D., Finn J., Wolfe F. Does exposure to immunosuppressive therapy increase the 10 year malignancy and mortality risks in rheumatoid arthritis? A matched cohort study // Br. J. Rheumatol. – 1996. – Vol. 35. – P. 738-745.
(check this in PDF content)
10
Knowles D.M. Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma // Hematol. Oncol. Clin. North Am. – 2003. – Vol. 17. – P. 785820.
(check this in PDF content)
11
Lejeune F.J., Ruegg C., Lienard D. Clinical applications of TNF-alpha in cancer // Curr. Opin. Immunol. – 1998. – Vol. 10. – P. 573-580.
(check this in PDF content)
12
Mariette X., Tubach F., Bagheri H., Bardet M., Berthelot J.M., Gaudin P., Heresbach D., Martin A., Schaeverbeke T., Salmon D., Lemann M., Hermine O., Raphael M., Ravaud P. Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry // Ann. Rheum. Dis. – Vol. 69. – P. 400-408.
(check this in PDF content)
13
Nissinen R., Leirisalo-Repo M., Peltomaa R., Palosuo T., Vaarala O. Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis // Ann. Rheum. Dis. – 2004. – Vol. 63. – P. 681-687.
(check this in PDF content)
14
Orosz P., Echtenacher B., Falk W., Ruschoff J., Weber D., Mannel D.N. Enhancement of experimental metastasis by tumor necrosis factor // J. Exp. Med. – 1993. – Vol. 177. – P. 1391-1398.
(check this in PDF content)
15
Paludan C., Munz C. CD4+ T cell responses in the immune control against latent infection by Epstein–Barr virus // Curr Mol Med. – 2003. – Vol. 3. – P. 341-347.
(check this in PDF content)
16
Shirinsky I.V., Zheltova O.I., Solovyova N.Y., Kozlov V.A., Shirinsky V.S. Changes in disease activity, cytokine production, and proliferation of peripheral blood mononuclear cells in patients with rheumatoid arthritis after simvastatin treatment // Scand. J. Rheumatol. – 2009. – Vol. 38. – P. 23-27.
(check this in PDF content)
17
Siebert F., Kalden J.R., Fink P., Fricke M., Deicher H. The effect of serum and allogeneic antiglobulin preparations on the mitogenic reactivity of peripheral blood lymphocytes from patients with rheumatoid arthritis // Z. Rheumatol. – 1978. – Vol. 37. – P. 286-295.
(check this in PDF content)
18
Brande J.M., Braat H., van den Brink G.R., Versteeg H.H., Bauer C.A., Hoedemaeker I., van Montfrans C., Hommes D.W., Peppelenbosch M.P., van Deventerм S.J. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease // Gastroenterology. – 2003. – Vol. 124. – P. 1774-1785.
(check this in PDF content)
19
Wolfe F.,Michaud K. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation // Arthritis Rheum. – 2007. – Vol. 56. – P. 1433-1439.
(check this in PDF content)
20
Wolfe А., Michaud K. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-TNF therapy in 18 572 patients // Arthritis Rheum. – 2003. – Vol. 48 (suppl.). – P. 242. поступила в редакцию 05.05.2010
(check this in PDF content)